Totem Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 22 Year, 2 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.37 M
- Satisfied Charges ₹ 2.50 M
- Revenue Growth -39.62%
- Profit Growth 7.75%
- Ebitda 2.53%
- Net Worth 7.37%
- Total Assets 11.32%
About Totem Biotech
Totem Biotech Private Limited (TBPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 February 2003 and has a history of 22 years. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.37 M. The company has closed loans amounting to ₹2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Archna Jaiswal and Manohar Jaiswal serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231GJ2003PTC042042
- Company No.
042042
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Feb 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Totem Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Archna Jaiswal  | Managing Director | 20-Feb-2003 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manohar Jaiswal | Whole-Time Director | 20-Feb-2003 | Current |
Financial Performance of Totem Biotech.
Totem Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 39.62% decrease. The company also saw a slight improvement in profitability, with a 7.75% increase in profit. The company's net worth moved up by a moderate rise of 7.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Totem Biotech?
In 2023, Totem Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aarpik Pharmaceuticals Private LimitedArchna Jaiswal and Manohar Jaiswal are mutual person
Aarpik Remedies Private LimitedArchna Jaiswal and Manohar Jaiswal are mutual person
Charges (Loans)
₹0.37 M
₹2.50 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Oct 2009 | Hdfc Bank Limited | ₹0.37 M | Open |
| 26 Sep 2006 | Bank Of India | ₹2.50 M | Satisfied |
How Many Employees Work at Totem Biotech?
Unlock and access historical data on people associated with Totem Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Totem Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Totem Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.